New drugs for lung diseases will be offered through SUS

New drugs for lung diseases will be offered in the SUS

The Brazilian Ministry of Health will offer four new drugs for lung diseases through the Unified Health System (SUS) in 2014. Bosentan and ambrisentan for pulmonary arterial hypertension. Erlotinib and gefitinib for patients with lung cancer. The MoH's Ordinance authorizing the inclusion of these new medicines was published today, November 8th in Brazil's Federal Official Gazette (D.O.U.)

Please login or register to read the full article.